期刊文献+

异位妊娠期待治疗成功的因素分析 被引量:18

Relative factors of expectant management of ectopic pregnancy
原文传递
导出
摘要 目的对异位妊娠期待治疗成功的因素进行回顾性分析。方法对山东大学齐鲁医院计划生育科2004年8月至2012年1月186例异位妊娠期待治疗病例进行回顾性分析,不需要手术或药物治疗为治愈组,需要手术或药物治疗的为失败组。结果140例期待治疗成功,治愈率75.27%;治愈组与失败组包块大小经秩和检验,差异无统计学意义(P〉0.05);两组包块有囊性结构患者例数差异有统计学意义(P〈0.05)。两组初始血β-人绒毛膜促性腺激素(hCG)差异有统计学意义(P〈0.01),初始血β—hCG在ROC曲线上临界点为634IU/L,第3~5天检测β-hCG与初始血β—hCG的比值在ROC曲线上临界点为0.711。结论初始血p—hCG≤634IU/L或第3~5天检测血β—hCG下降为初始的0.711倍时,可期待治疗。包块有无囊性结构是影响期待治疗成功的因素。 Objective To analyze select patients of ectopic pregnancy for expectant management. Methods Retrospective analyses were conducted for the relative factors of 180 cases of ectopic pregnancy with expectant management at Department of Family Planning of our hospital from August 2004 to January 2012. Their general clinical data, clinical manifestations and laboratory tests were collected. The eases requiring neither surgery nor drug therapy belonged to the cure group while the rest fell into the failure group. Results A total of 140 patients were successfully managed with a cure rate of 75.27%. There was no significant difference between two groups in size of mass on ultrasonography ( P 〉 0.05 ). The cases with gestational sac of mass on ultrasonography had statistical difference between two groups (P 〈0. 05). Statistical difference existed between two groups ( P 〈 0. 01 ) in initial blood beta-human chorionie gonadotropin (β-hCG), initial blood β-hCG and D3 -5/D0 (ratio of blood β-hCG at day 3 -5 and initial) were the variables for predicting the likelihood of successful expectant management under the ROC curve. The Youden Index was the largest at an initial bloodβ-hCG of 634 IU/L or D3 -5/DO of 0. 711. Conclusion At bloodβ-hCG≤634 IU/L or D3 -5/DO 〈 0. 711, expectant management may be offered. And mass with gestational sac on ultrasonography is a relative factor of expectant management.
出处 《中华医学杂志》 CAS CSCD 北大核心 2013年第15期1165-1167,共3页 National Medical Journal of China
关键词 妊娠 异位 治疗 临床研究性 绒毛膜促性腺激素 Pregnancy Ectopic Therapies, investigational Chorionic gonadotropin
  • 相关文献

参考文献8

  • 1丁志明,叶大风,吕卫国,谢幸,程晓东,黄秀峰.甲氨蝶呤单剂治疗未破裂异位妊娠有效性和安全性的分析[J].中华医学杂志,2003,83(19):1704-1705. 被引量:3
  • 2Van Mello MN, Mol F, Adriaanse AH, et al. The METE study: methotrexate versus expectant management in women with ectopic pregnancy:a randomised controlled trial. BMC Women's Health, 2008, 8:663-665.
  • 3Strobeh N, Mariani E, Ferrari L, et al. Fertility after ectopic pregnancy. J Reprod Med,2000,45:803-807.
  • 4Trio D, Strobelt N, Picciolo C, et al. Prognostic factors for successful expectant management of ectopic pregnancy. Fertil Steril, 1995, 63:469-472.
  • 5Kirk E, VAN Calster B, Condous G, et al. Ectopic pregnancy: using the hCG ratio to select women for expectant or medical management. Acta Obstet Gynecol Seand, 2011,90:264-272.
  • 6F.GaryCunningham.威廉姆斯产科学.21版,北京:科学出版社.2002:890-891.
  • 7Stova11 Tg, Ling Fw, Carson Sa, et al. Serum progesterone and uterine curettage in differential diagnosis of ectopic pregnancy. Fertil Steril, 1992,57:456-458.
  • 8Elson J, Tailor A, Banerjee S, et al. Expectant management of tubal ectopic pregnancy: prediction of successful outcome using decision tree analysis. Ultraso Obstet Gynecol, 2004, 23:552-556.

二级参考文献5

  • 1American college of obstetricians and gynecologists. Medical management of tubal pregnancy. ACOG practice bulletin 3. Inter J Gynecol Obstet, 1999, 65:97-103.
  • 2Stovall TG, Ling FW. Single-dose methotrexate: an expanded clinical trial. Am J Obstet Gynecol,1993,168:1759-1765.
  • 3Stovall TG, Ling FW. Ectopic pregnancy: diagnostic and theraputic algorithms minimizing surgical intervention. J Reprod Med, 1993,38:807-812.
  • 4周际昌.抗肿瘤药的不良反应及其处理.见:周际昌,主编.实用肿瘤内科学.北京:人民卫生出版社,1997. 23.Zhou JC. Untoward reaction of antitumor agents and management. In: Zhou JC,ed. Practice of medical oncology. First ed. Beijing: People Health Press,1997.23.
  • 5Lipscomb GH,Stovall TG,Ling FW, et al. Nonsurgical treatment of ectopic pregnancy. N Engl J Med, 2000,343:1325-1329.

共引文献2

同被引文献158

  • 1张映辉,钟梅.血清β绒毛膜促性腺激素、孕酮及雌二醇检测用于早期异位妊娠诊断的价值[J].中华临床医师杂志(电子版),2011,5(23):7112-7114. 被引量:21
  • 2张玲.异位妊娠药物治疗两种方案比较[J].药物流行病学杂志,2006,15(3):142-143. 被引量:4
  • 3林彩霞.超声检查在异位妊娠诊断治疗中的作用[J].中国现代医生,2007,45(06Z):72-73. 被引量:12
  • 4孔北华.妇产科学[M].北京:高等教育出版社,2011:348.
  • 5谢幸,苟文丽.妇产科学[M].8版.北京:人民卫生出版社,2013:118-119.
  • 6Deans R, Abbott J. Hysteroscopic management of cesarean scar ectopic pregnancy[J]. Fertil Steril, 2010, 93 (6): 1735.
  • 7van Mello N M, Mol F, Adriaanse A H, et al. The METEX study: methotrexate versus expectant management in womenwith ectopic pregnancy: a randomised controlled trial [J]. BMC Womens Health, 2008, 8: 10.
  • 8Kirk E, Van Calster B, Condous G, et al. Ectopic pregnan- cy: using the hCG ratio to select women for expectant or medical management[J ]. Aeta Obstet Gynecol Stand, 2011, 90(3) : 264.
  • 9Jagadambe A, Oakeshott P, Ojha K, et al. Methods of as- sessing tubal patency[J]. Sex Transm Infect, 2012, 88(4) : 249.
  • 10Nama V, Manyonda I. Tubal ectopic pregnancy: diagnosis and management[J]. Arch Gynecol Obstet, 2009, 279(4): 443.

引证文献18

二级引证文献165

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部